UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Review of the epidemiology of overactive bladder

Research and reports in urology, 2016-01, Vol.8 (Issue 1), p.71-76

2016

Link zum Volltext

Verfügbarkeit prüfen

Role of FDG PET/CT in Management of Patients with Prostate Cancer

Seminars in nuclear medicine, 2024-01, Vol.54 (1), p.4-13

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of the United States Preventive Services Task Force ‘D’ recommendation on prostate cancer screening and staging

Current opinion in urology, 2017-05, Vol.27 (3), p.205-209

2017

Link zum Volltext

Verfügbarkeit prüfen

The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer

Cancers, 2024-02, Vol.16 (5), p.939

2024

Link zum Volltext

Verfügbarkeit prüfen

Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer

Radiation oncology (London, England), 2024-02, Vol.19 (1), p.23-23

2024

Link zum Volltext

Verfügbarkeit prüfen

Gender differences in overactive bladder

Canadian journal of urology, 2016-02, Vol.23 (Suppl 1), p.2

2016

Link zum Volltext

Verfügbarkeit prüfen

Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier

Urologic clinics of North America, 2017-11, Vol.44 (4), p.547-555

2017

Link zum Volltext

Verfügbarkeit prüfen

Practice patterns of primary EBRT with and without ADT in prostate cancer treatment

Prostate cancer and prostatic diseases, 2019-03, Vol.22 (1), p.117-124

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma

European urology open science (Online), 2022-10, Vol.44, p.60-68

2022

Link zum Volltext

Verfügbarkeit prüfen

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

Contemporary clinical trials communications, 2023-06, Vol.33, p.101145-101145, Article 101145

2023

Link zum Volltext

Verfügbarkeit prüfen

Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

European urology, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Re: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence (NOSTONE)

European urology, 2023-09, Vol.84 (3), p.353-354

2023

Link zum Volltext

Verfügbarkeit prüfen

MP41-07 PRESENTATION SKILLS IN THE VIRTUAL MEETING ERA – AN ANALYSIS OF #EAU21

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Link zum Volltext

Verfügbarkeit prüfen

Re: A Comparative Study of Robot-assisted and Open Radical Prostatectomy in 10 790 Men Treated by Highly Trained Surgeons for Both Procedures

European urology, 2020-02, Vol.77 (2), p.285-286

2020

Link zum Volltext

Verfügbarkeit prüfen

High-flow post-traumatic priapism with delayed presentation

BMJ case reports, 2022-04, Vol.15 (4), p.e249513

2022

Link zum Volltext

Verfügbarkeit prüfen

Prostate‐specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer

BJU international, 2022-11, Vol.130 (S3), p.8-10

2022

Link zum Volltext

Verfügbarkeit prüfen

Indocyanine green in minimally and maximally invasive genitourinary cancer surgery

BJU international, 2024-04, Vol.133 (4), p.400-402

2024

Link zum Volltext

Verfügbarkeit prüfen

The application of theranostics in different stages of prostate cancer

Future oncology (London, England), 2021-09, Vol.17 (27), p.3637-3644

2021

Link zum Volltext

Verfügbarkeit prüfen

Study of the dosimetry, safety, and potential benefit of 177Lu-PSMA-617 radionuclide therapy prior to radical prostatectomy in men with high-risk localized prostate cancer (LuTectomy study)

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.TPS264-TPS264

2021

Link zum Volltext

Verfügbarkeit prüfen

The Clinical Applications of Tissue Biomarkers in Prostate Cancer

Société internationale d'urologie journal, 2020-10, Vol.1 (1), p.23-29

Peter Lonergan, Samuel Washington, Maxwell Meng, Renu Eapen

2020

Link zum Volltext

Verfügbarkeit prüfen

Whom to Treat

Urologic clinics of North America, 2017-11, Vol.44 (4), p.547-555

2017

Link zum Volltext

Verfügbarkeit prüfen

Migration of an established pre‐operative education session for robot‐assisted radical prostatectomy patients to telehealth: A quality improvement initiative

International journal of urological nursing, 2023-07, Vol.17 (2), p.145-145

2023

Link zum Volltext

Verfügbarkeit prüfen

MP96-10 INITIAL VALIDATION OF AUTOMATED DATA EXTRACTION METHODS IN UROLOGIC ONCOLOGY PRACTICE

The Journal of urology, 2017-04, Vol.197 (4), p.e1298-e1298

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(46)
magazinearticle
(1)

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Review of the epidemiology of overactive bladder

Role of FDG PET/CT in Management of Patients with Prostate Cancer

Impact of the United States Preventive Services Task Force ‘D’ recommendation on prostate cancer screening and staging

Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study

The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer

Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer

Gender differences in overactive bladder

Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier

Practice patterns of primary EBRT with and without ADT in prostate cancer treatment

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

Re: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence (NOSTONE)

MP41-07 PRESENTATION SKILLS IN THE VIRTUAL MEETING ERA – AN ANALYSIS OF #EAU21

Re: A Comparative Study of Robot-assisted and Open Radical Prostatectomy in 10 790 Men Treated by Highly Trained Surgeons for Both Procedures

High-flow post-traumatic priapism with delayed presentation

Prostate‐specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer

Indocyanine green in minimally and maximally invasive genitourinary cancer surgery

The application of theranostics in different stages of prostate cancer

The Dedicated Imaging Post‐Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low‐risk biochemical recurrence after radical prostatectomy

Study of the dosimetry, safety, and potential benefit of 177Lu-PSMA-617 radionuclide therapy prior to radical prostatectomy in men with high-risk localized prostate cancer (LuTectomy study)

The Clinical Applications of Tissue Biomarkers in Prostate Cancer

Whom to Treat

Migration of an established pre‐operative education session for robot‐assisted radical prostatectomy patients to telehealth: A quality improvement initiative

MP96-10 INITIAL VALIDATION OF AUTOMATED DATA EXTRACTION METHODS IN UROLOGIC ONCOLOGY PRACTICE

Suchergebnisse filtern